Befejeződött2. fázis
Short-term Pre-OPerative Durvalumab (MEDI 4736) in early small triple negative breast cancer patients (POP-Durva)
Key facts
- Where
- Bordeaux, Clermont-Ferrand, Lyon és Villejuif, FranciaországSee the 4 sites
- Phase
- 2. fázis
Where in Franciaország
- Institut BergonieBordeaux, FranciaországNo longer taking part
- Centre Jean PerrinClermont-Ferrand, FranciaországNo longer taking part
- Centre Leon BerardLyon, FranciaországNo longer taking part
- Institut Gustave RoussyVillejuif, FranciaországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institut Gustave Roussy
- Trial code
- EU 2024-512082-14-00
- Record updated
- 2026. június 15.